| Code | Description | Claims | Beneficiaries | Total Paid |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,992 |
1,783 |
$132K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,076 |
1,796 |
$108K |
| 92134 |
|
4,477 |
3,960 |
$87K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,772 |
1,580 |
$74K |
| 92226 |
|
1,982 |
1,067 |
$26K |
| 92201 |
|
1,190 |
833 |
$25K |
| J9035 |
Injection, bevacizumab, 10 mg |
336 |
297 |
$24K |
| J0178 |
Injection, aflibercept, 1 mg |
15 |
12 |
$11K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
101 |
100 |
$10K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
15 |
13 |
$10K |
| 99233 |
Prolong inpt eval add15 m |
82 |
55 |
$6K |
| 92202 |
|
378 |
353 |
$3K |
| 92225 |
|
146 |
75 |
$2K |
| 5010F |
|
19 |
13 |
$0.00 |